Reported about 14 hours ago
Gilead Sciences, Inc. (GILD) is highlighted as one of the top stocks to buy according to Jim Simons’ Renaissance Technologies, ranking 10th on their list. Despite a slight decline in total product sales, Gilead's core business remains strong, particularly in HIV treatments, which account for a significant portion of its revenue. The company also plans to invest $11 billion to enhance its manufacturing and research capabilities in the U.S. However, some experts suggest that certain AI stocks may offer higher potential for returns compared to Gilead.
Source: YAHOO